11 – 20 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
“C1-inhibitor levels and Venous Thromboembolism : Results from a Mendelian Randomization Study”: comment from Grover et al
(
- Contribution to journal › Letter
-
Mark
Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII
(
- Contribution to journal › Article
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
-
Mark
Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders
(
- Contribution to journal › Article
-
Mark
Natural anticoagulant discovery, the gift that keeps on giving : finding FV-Short
(
- Contribution to journal › Scientific review
- 2022
-
Mark
The preAR2 region (1458–1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study
(
- Contribution to journal › Article
-
Mark
Hereditary angioedema is associated with an increased risk of venous thromboembolism
(
- Contribution to journal › Letter
-
Mark
Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Diagnosis and management of severe congenital protein C deficiency (SCPCD) : Communication from the SSC of the ISTH
(
- Contribution to journal › Article